U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 4 Glomerular Filtration Rate, CTCAE

MedGen UID:
326283
•Concept ID:
C1559914
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 4 Glomerular Filtration Rate, CTCAE

Professional guidelines

PubMed

Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients.
Zazuli Z, Otten LS, Drögemöller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, McGoldrick N, Kitchlu A, Vijverberg SJH, Masereeuw R, Ross CJD, Liu G, Carleton BC, Maitland-van der Zee AH
Genes (Basel) 2019 May 10;10(5) doi: 10.3390/genes10050364. PMID: 31083486Free PMC Article

Recent clinical studies

Etiology

Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Duan H, Ferri V, Fisher GA, Shaheen S, Davidzon GA, Iagaru A, Mari Aparici C
Oncologist 2022 Jun 8;27(6):447-452. doi: 10.1093/oncolo/oyab072. PMID: 35641196Free PMC Article
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Ikesue H, Yamamoto H, Hirabatake M, Hashida T, Chung H, Inokuma T, Muroi N
Biol Pharm Bull 2022;45(3):333-338. doi: 10.1248/bpb.b21-00913. PMID: 35228399
Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Widjaja L, Derlin T, Ross TL, Bengel FM, Werner RA
Prostate 2022 Jan;82(1):86-96. Epub 2021 Oct 11 doi: 10.1002/pros.24250. PMID: 34633090
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique.
Durie E, Nicholson E, Anthias C, Dunne EM, Potter M, Ethell M, Messiou C, Brennan J, Eagle S, Talbot J, Smyth G, Ingram W, Saran F, Mandeville HC
Radiother Oncol 2021 May;158:97-103. Epub 2021 Feb 23 doi: 10.1016/j.radonc.2021.02.020. PMID: 33636231
A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
Dhillon P, Amir E, Lo M, Kitchlu A, Chan C, Cochlin S, Yip P, Chen E, Lee R, Ng P
J Oncol Pharm Pract 2019 Jun;25(4):875-883. Epub 2018 May 3 doi: 10.1177/1078155218771461. PMID: 29722605

Diagnosis

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Widjaja L, Derlin T, Ross TL, Bengel FM, Werner RA
Prostate 2022 Jan;82(1):86-96. Epub 2021 Oct 11 doi: 10.1002/pros.24250. PMID: 34633090
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique.
Durie E, Nicholson E, Anthias C, Dunne EM, Potter M, Ethell M, Messiou C, Brennan J, Eagle S, Talbot J, Smyth G, Ingram W, Saran F, Mandeville HC
Radiother Oncol 2021 May;158:97-103. Epub 2021 Feb 23 doi: 10.1016/j.radonc.2021.02.020. PMID: 33636231
Risk factors associated with significant bleeding events after ultrasound-guided percutaneous native renal biopsies: a review of 2204 cases.
Monahan H, Gunderson T, Greene E, Schmit G, Atwell T, Schmitz J
Abdom Radiol (NY) 2019 Jun;44(6):2316-2322. doi: 10.1007/s00261-019-01962-z. PMID: 30830293
177Lu-DOTATATE PRRT in Patients with Metastatic Neuroendocrine Tumor and a Single Functioning Kidney: Tolerability and Effect on Renal Function.
Ranade R, Basu S
J Nucl Med Technol 2016 Jun;44(2):65-9. Epub 2016 Feb 4 doi: 10.2967/jnmt.115.168146. PMID: 26848166

Therapy

Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease.
Cantarelli L, Gutiérrez Valencia M, Leache Alegria L, Sainz Fernandez LC, Erviti Lopez J, Gutiérrez Nicolas F, Nazco Casariego GJ
Med Clin (Barc) 2024 Jul 12;163(1):1-7. Epub 2024 Apr 16 doi: 10.1016/j.medcli.2024.01.026. PMID: 38616432
Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Duan H, Ferri V, Fisher GA, Shaheen S, Davidzon GA, Iagaru A, Mari Aparici C
Oncologist 2022 Jun 8;27(6):447-452. doi: 10.1093/oncolo/oyab072. PMID: 35641196Free PMC Article
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Ikesue H, Yamamoto H, Hirabatake M, Hashida T, Chung H, Inokuma T, Muroi N
Biol Pharm Bull 2022;45(3):333-338. doi: 10.1248/bpb.b21-00913. PMID: 35228399
Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Widjaja L, Derlin T, Ross TL, Bengel FM, Werner RA
Prostate 2022 Jan;82(1):86-96. Epub 2021 Oct 11 doi: 10.1002/pros.24250. PMID: 34633090
A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
Dhillon P, Amir E, Lo M, Kitchlu A, Chan C, Cochlin S, Yip P, Chen E, Lee R, Ng P
J Oncol Pharm Pract 2019 Jun;25(4):875-883. Epub 2018 May 3 doi: 10.1177/1078155218771461. PMID: 29722605

Prognosis

Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Duan H, Ferri V, Fisher GA, Shaheen S, Davidzon GA, Iagaru A, Mari Aparici C
Oncologist 2022 Jun 8;27(6):447-452. doi: 10.1093/oncolo/oyab072. PMID: 35641196Free PMC Article
Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Widjaja L, Derlin T, Ross TL, Bengel FM, Werner RA
Prostate 2022 Jan;82(1):86-96. Epub 2021 Oct 11 doi: 10.1002/pros.24250. PMID: 34633090
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique.
Durie E, Nicholson E, Anthias C, Dunne EM, Potter M, Ethell M, Messiou C, Brennan J, Eagle S, Talbot J, Smyth G, Ingram W, Saran F, Mandeville HC
Radiother Oncol 2021 May;158:97-103. Epub 2021 Feb 23 doi: 10.1016/j.radonc.2021.02.020. PMID: 33636231
Risk factors associated with significant bleeding events after ultrasound-guided percutaneous native renal biopsies: a review of 2204 cases.
Monahan H, Gunderson T, Greene E, Schmit G, Atwell T, Schmitz J
Abdom Radiol (NY) 2019 Jun;44(6):2316-2322. doi: 10.1007/s00261-019-01962-z. PMID: 30830293
A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
Dhillon P, Amir E, Lo M, Kitchlu A, Chan C, Cochlin S, Yip P, Chen E, Lee R, Ng P
J Oncol Pharm Pract 2019 Jun;25(4):875-883. Epub 2018 May 3 doi: 10.1177/1078155218771461. PMID: 29722605

Clinical prediction guides

Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease.
Cantarelli L, Gutiérrez Valencia M, Leache Alegria L, Sainz Fernandez LC, Erviti Lopez J, Gutiérrez Nicolas F, Nazco Casariego GJ
Med Clin (Barc) 2024 Jul 12;163(1):1-7. Epub 2024 Apr 16 doi: 10.1016/j.medcli.2024.01.026. PMID: 38616432
Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Duan H, Ferri V, Fisher GA, Shaheen S, Davidzon GA, Iagaru A, Mari Aparici C
Oncologist 2022 Jun 8;27(6):447-452. doi: 10.1093/oncolo/oyab072. PMID: 35641196Free PMC Article
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Ikesue H, Yamamoto H, Hirabatake M, Hashida T, Chung H, Inokuma T, Muroi N
Biol Pharm Bull 2022;45(3):333-338. doi: 10.1248/bpb.b21-00913. PMID: 35228399
Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy.
Widjaja L, Derlin T, Ross TL, Bengel FM, Werner RA
Prostate 2022 Jan;82(1):86-96. Epub 2021 Oct 11 doi: 10.1002/pros.24250. PMID: 34633090
A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
Dhillon P, Amir E, Lo M, Kitchlu A, Chan C, Cochlin S, Yip P, Chen E, Lee R, Ng P
J Oncol Pharm Pract 2019 Jun;25(4):875-883. Epub 2018 May 3 doi: 10.1177/1078155218771461. PMID: 29722605

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...